home / stock / bvnkf / bvnkf quote
Last: | $21.20 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $21.20 |
High: | $0 |
Low: | $0 |
Volume: | 1,003 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$21.2 | $0 | $21.2 | $0 | $0 | 1,003 | 05-17-2024 |
$21.2 | $0 | $21.2 | $0 | $0 | 3 | 05-16-2024 |
$21.2 | $0 | $21.2 | $0 | $0 | 1 | 05-15-2024 |
$21.2 | $0 | $21.2 | $0 | $0 | 2 | 05-13-2024 |
$21.2 | $0 | $21.2 | $0 | $0 | 10 | 05-10-2024 |
$21.2 | $21.2 | $21.2 | $21.2 | $21.2 | 305 | 05-09-2024 |
$20.45 | $0 | $20.45 | $0 | $0 | 5 | 05-07-2024 |
$20.45 | $20.45 | $20.45 | $20.45 | $20.45 | 444 | 05-06-2024 |
$18.72 | $0 | $18.72 | $0 | $0 | 20 | 05-03-2024 |
$18.72 | $0 | $18.72 | $0 | $0 | 9 | 05-02-2024 |
$18.72 | $0 | $18.72 | $0 | $0 | 9 | 04-29-2024 |
$18.72 | $0 | $18.72 | $0 | $0 | 60 | 04-25-2024 |
$18.72 | $0 | $18.72 | $0 | $0 | 7 | 04-23-2024 |
$18.72 | $0 | $18.72 | $0 | $0 | 60 | 04-22-2024 |
$18.72 | $18.72 | $18.72 | $18.72 | $18.72 | 400 | 04-18-2024 |
$22.6 | $0 | $22.6 | $0 | $0 | 1 | 04-15-2024 |
$22.6 | $0 | $22.6 | $0 | $0 | 10 | 04-10-2024 |
$22.6 | $0 | $22.6 | $0 | $0 | 10 | 04-08-2024 |
$22.6 | $0 | $22.6 | $0 | $0 | 17 | 04-02-2024 |
$22.6 | $22.6 | $22.6 | $22.6 | $22.6 | 106 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Bavarian Nordic R/I Ord Company Name:
BVNKF Stock Symbol:
OTCMKTS Market:
COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration (FDA) for a Biologics License Application (BLA) for the licensure of its CHIKV VLP vaccine candidate for i...
COPENHAGEN, Denmark, April 2, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS ® , the only FDA-approved mpox vaccine, is now commercially available in the U.S., marking a significant expansion for access to JYNNEOS ® by establishing additional pathwa...
Accelerated assessment allows for a shorter review period with EMA. Bavarian Nordic is on track to submit its Marketing Authorisation Application for CHIKV VLP to EMA during H1 2024. COPENHAGEN, Denmark, February 23, 2024 – Bavarian Nordic A/S (OMX: BAVA) (“the Company...